3rd Quarter - Amendment

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$2,870,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2025 $2,730,000 Replaced
3rd Quarter - Amendment Jan 23, 2026 $2,810,000 Replaced
3rd Quarter - Amendment (this page) Mar 12, 2026 $2,870,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing

LobbyistCovered position, as disclosed
FRANCISCO CARRILLO —
EMILY MUELLER —
CATHERINE ROBINSON —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —
ANGELA BOOTHE WILES —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5256 (119th), H.R. 4317 (119th), H.R. 2214 (119th)

Medicare/Medicaid MMM

Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics

LobbyistCovered position, as disclosed
FRANCISCO CARRILLO —
EMILY MUELLER —
ANGELA BOOTHE WILES —

Contacted: SENATE

Trade (domestic/foreign) TRD

International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Treasury, Dept of; Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.